4MA3 image
Deposition Date 2013-08-15
Release Date 2014-03-26
Last Version Date 2024-10-16
Entry Detail
PDB ID:
4MA3
Keywords:
Title:
Crystal structure of anti-hinge rabbit antibody C2095
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:C2095 heavy chain
Chain IDs:B (auth: H), D (auth: B)
Chain Length:223
Number of Molecules:2
Biological Source:Oryctolagus cuniculus, Homo sapiens
Polymer Type:polypeptide(L)
Molecule:C2095 light chain
Chain IDs:A (auth: L), C (auth: A)
Chain Length:220
Number of Molecules:2
Biological Source:Oryctolagus cuniculus, Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PCA A GLN PYROGLUTAMIC ACID
Primary Citation
Structure and specificity of an antibody targeting a proteolytically cleaved IgG hinge.
Proteins 82 1656 1667 (2014)
PMID: 24638881 DOI: 10.1002/prot.24545

Abstact

The functional role of human antihinge (HAH) autoantibodies in normal health and disease remains elusive, but recent evidence supports their role in the host response to IgG cleavage by proteases that are prevalent in certain disorders. Characterization and potential exploitation of these HAH antibodies has been hindered by the absence of monoclonal reagents. 2095-2 is a rabbit monoclonal antibody targeting the IdeS-cleaved hinge of human IgG1. We have determined the crystal structure of the Fab of 2095-2 and its complex with a hinge analog peptide. The antibody is selective for the C-terminally cleaved hinge ending in G236 and this interaction involves an uncommon disulfide in VL CDR3. We probed the importance of the disulfide in VL CDR3 through engineering variants. We identified one variant, QAA, which does not require the disulfide for biological activity or peptide binding. The structure of this variant offers a starting point for further engineering of 2095-2 with the same specificity, but lacking the potential manufacturing liability of an additional disulfide. Proteins 2014; 82:1656-1667. © 2014 Wiley Periodicals, Inc.

Legend

Protein

Chemical

Disease

Primary Citation of related structures